Jonathan Schoen
4 Papers
Jonathan Schoen is an academic researcher. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 2, co-authored 3 publications.
Chat about Author
Papers
Exploring visceral and subcutaneous adipose tissue secretomes in human obesity: implications for metabolic disease.
Darcy E. Kahn,Emily Macias,Simona Zarini,A. Garfield,Karin A. Zemski Berry,Paul S. MacLean,Robert E. Gerszten,Andrew E. Libby,Claudia M. Solt,Jonathan Schoen,Bryan C. Bergman +10 more
TL;DR: The unique secretome of VAT has distinct and negative impact on hepatocyte and muscle insulin action and differences in immune/inflammatory response and extracellular matrix components are revealed.
42
Quantifying the inflammatory secretome of human intermuscular adipose tissue
Darcy E. Kahn,Emily Macias,Simona Zarini,A. Garfield,Karin A. Zemski Berry,Robert E. Gerszten,Jonathan Schoen,Melanie Cree-Green,Bryan C. Bergman +8 more
TL;DR: In the context of obesity, IMAT is a distinct adipose tissue with a highly immunogenic and inflammatory secretome, and given its proximity to skeletal muscle, may be critical to glucose regulation and insulin resistance.
20
Glycerol as a precursor for hepatic de novo glutathione synthesis in human liver
Eunsook S. Jin,Craig R. Malloy,Gaurav Sharma,Erin M Finn,Kelly N. Z. Fuller,Yesenia Garcia Reyes,Mark A. Lovell,S. Christopher Derderian,Jonathan Schoen,Thomas H. Inge,Melanie G. Cree +10 more
TL;DR: Glycerol incorporation into glutathione through glycine or glutamate metabolism in human liver was reported in this paper , which could represent a compensatory mechanism to increase glutathion in the setting of excess glycerol delivery to the liver.
9
OR15-03 Lower Hepatic Mitochondrial Respiration Relates To Dysmetabolism In Adolescents With Severe Obesity
Erin Finn,Kelly N Z Fuller,Leslie A Knaub,Yesenia Garcia Reyes,S. C. Derderian,Jonathan Schoen,Thomas Inge,Jane E Reusch,Kristen Nadeau,Melanie G Cree +9 more
TL;DR: Youth with severe obesity have lower hepatic mitochondrial respiration which correlates with markers of poorer cardiometabolic health including higher triglycerides, higher glucose concentraions, lower insulin sensitivity, higher insulin secretion (C-peptide), and higher liver transaminases.